Group 1 (n = 56) | Group 2 (n = 34) | Group 3 (n = 46) | |||||
---|---|---|---|---|---|---|---|
mean ± SD | median | mean ± SD | median | mean ± SD | median | p-value* | |
Total scale | |||||||
ISF:8 | 5.66 ± 3.73 | 5.00 | 8.50 ± 4.61 | 8.00 | 6.93 ± 4.23 | 6.00 | <0.001 |
ISF:16 | 9.63 ± 7.78 | 7.00 | 12.94 ± 5.55 | 13.00 | 13.98 ± 8.4 | 12.00 | <0.001 |
Subscale | |||||||
Oral Symptoms | |||||||
ISF:8 | 2.07 ± 1.33 | 2.00 | 3.09 ± 1.24 | 3.00 | 2.15 ± 1.60 | 2.00 | <0.001 |
ISF:16 | 3.43 ± 2.45 | 3.00 | 5.18 ± 2.02 | 5.50 | 4.28 ± 2.50 | 4.00 | <0.001 |
Functional limitations | |||||||
ISF:8 | 1.80 ± 1.86 | 1.00 | 2.59 ± 1.87 | 2.50 | 1.74 ± 1.58 | 2.00 | 0.06 |
ISF:16 | 2.70 ± 2.52 | 2.00 | 3.68 ± 1.99 | 3.00 | 3.78 ± 2.40 | 4.00 | 0.01 |
Emotional well-being | |||||||
ISF:8 | 1.02 ± 1.43 | 0.00 | 1.47 ± 1.46 | 1.00 | 1.13 ± 1.37 | 1.00 | 0.22 |
ISF:16 | 2.16 ± 2,36 | 2.00 | 2.68 ± 2.40 | 2.00 | 3.15 ± 2.54 | 2.50 | 0.07 |
Social well-being | |||||||
ISF:8 | 0.77 ± 0.99 | 0.00 | 1.35 ± 1.39 | 1.00 | 1.91 ± 1.50 | 2.00 | <0.001 |
ISF:16 | 1.34 ± 2.20 | 0.00 | 1.41 ± 1.37 | 1.00 | 2.76 ± 2.56 | 2.00 | <0.001 |